Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
SxWVZF6D10ARnrhP
Listen
